Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
American Journal of Hospital Pharmacy|July 1, 1993
Reimbursement and pharmacoeconomic perspectives in biotechnologyG C BleeckerThe EMBO Journal|June 1, 1987
Sequences controlling histone H4 mRNA abundanceO Capasso, G C Bleecker, N HeintzMolecular and Cellular Biology|February 1, 1985
Identification of promoter elements necessary for transcriptional regulation of a human histone H4 gene in vitroS M Hanly, G C Bleecker, N HeintzEuropean Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Cost-effectiveness analyses in a changing health care environment: new issues and challengesM J Strauss, G C Bleecker, A B SteinwaldAnnals of Emergency Medicine|October 1, 1992
Hospital delays and problems with thrombolytic administration in patients receiving thrombolytic therapy: a multicenter prospective assessment. Virginia Thrombolytic Study GroupE R Gonzalez, L A Jones, J P Ornato, et al.The Annals of Pharmacotherapy|November 1, 1992
Adjunctive medications in patients receiving thrombolytic therapy: a multicenter prospective assessment. The Virginia Multicenter Thrombolytic Study GroupE R Gonzalez, L A Jones, J P Ornato, et al.Transfusion|May 1, 1991
Blood transfusion costs: a multicenter studyJ M Forbes, M D Anderson, G F Anderson, et al.Transfusion|January 3, 2001
Economic consequences of alterations in platelet transfusion dose: analysis of a prospective, randomized, double-blind trialS J Ackerman, T R Klumpp, G I Guzman, et al.Pharmacoeconomics|March 8, 1998
Pharmacoeconomic analysis of 3 treatment strategies for cytomegalovirus retinitis in patients with AIDSR I Griffiths, G C Bleecker, D A Jabs, et al.Transfusion|July 21, 1999
Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trialT R Klumpp, J H Herman, J P Gaughan, et al.Pageof 1